Product  Name: Cilengitide
Cas No: 188968-51-6
Formula: C27H40N8O7
Molecular:588.65
Sequence: Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-N-methyl-L-valyl)
Purity:98%
Appearance: white powder
Source: synthetic

Cilengitide is a peptide that inhibits the integrin receptor, which may be involved in tumorigenesis. It blocks the process of cellular transformation and inhibits tumor growth by blocking angiogenesis. Cilengitide has been shown to have minimal toxicity in vitro and in vivo, which is likely due to its low solubility in water. This peptide also has antitumor activity against solid tumours and can inhibit the growth of human breast cancer cells. Cilengitide was found to be effective in an experimental model using MDA-MB-231 breast cancer cells, demonstrating its potential for use as a therapeutic agent for cancer treatment.

HOT SELLING

Semaglutide CAS 910463-68-2

Tirzepatide CAS 2023788-19-2

Retatrutide CAS 2381089-83-2

Liaglutide CAS 204656-20-2

Octreotide CAS79517-01-4

Dulaglutide CAS 923950-08-7

LixisenatideAcetate CAS 320367-13-3

Teduglutide CAS 197922-42-2

Albiglutide CAS 782500-75-8

Degarelix CAS 214766-78-6

Cilengitide CAS 188968-51-6

Mifamurtide CAS 83461-56-7

Somatostatin CAS 51110-01-1

Exenatide Acetate CAS 141732-76-5

Pramlintide CAS 151126-32-8

Eptifibatide CAS 188627-80-7

Bivalirudin CAS 128270-60-0

Semax CAS 80714-61-0

Contact information